TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS

The review article provides with recent data on the crucial cardiology problems — duration of double antiplatelet therapy (DAPT) in patients with different types of ischemic heart disease. The analysis is provided of actual clinical guidelines on this issue, the results of recent clinical trials are...

Full description

Saved in:
Bibliographic Details
Main Authors: O. L. Barbarash, V. V. Kashtalap
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2016-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/520
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850029041506058240
author O. L. Barbarash
V. V. Kashtalap
author_facet O. L. Barbarash
V. V. Kashtalap
author_sort O. L. Barbarash
collection DOAJ
description The review article provides with recent data on the crucial cardiology problems — duration of double antiplatelet therapy (DAPT) in patients with different types of ischemic heart disease. The analysis is provided of actual clinical guidelines on this issue, the results of recent clinical trials are highlighted, as of metaanalyses. Based on the results of international trials, the necessity postulated of thorough assessment of risk and safety for either prolongation or shortening of DAPT, and some possible indications provided for these changes in 12-month DAPT.
format Article
id doaj-art-beef3867d9214eaf8fca0c5a6b8b2c01
institution DOAJ
issn 1560-4071
2618-7620
language Russian
publishDate 2016-02-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-beef3867d9214eaf8fca0c5a6b8b2c012025-08-20T02:59:38Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202016-02-0102758310.15829/1560-4071-2016-2-75-83499TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONSO. L. Barbarash0V. V. Kashtalap1Research Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical Academy of the Ministry of HealthResearch Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical Academy of the Ministry of HealthThe review article provides with recent data on the crucial cardiology problems — duration of double antiplatelet therapy (DAPT) in patients with different types of ischemic heart disease. The analysis is provided of actual clinical guidelines on this issue, the results of recent clinical trials are highlighted, as of metaanalyses. Based on the results of international trials, the necessity postulated of thorough assessment of risk and safety for either prolongation or shortening of DAPT, and some possible indications provided for these changes in 12-month DAPT.https://russjcardiol.elpub.ru/jour/article/view/520double antiplatelet therapydurationischemic eventsbleedingsaspirintienopyridines
spellingShingle O. L. Barbarash
V. V. Kashtalap
TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS
Российский кардиологический журнал
double antiplatelet therapy
duration
ischemic events
bleedings
aspirin
tienopyridines
title TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS
title_full TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS
title_fullStr TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS
title_full_unstemmed TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS
title_short TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS
title_sort timeline for the double antiplatelet therapy facts and suggestions
topic double antiplatelet therapy
duration
ischemic events
bleedings
aspirin
tienopyridines
url https://russjcardiol.elpub.ru/jour/article/view/520
work_keys_str_mv AT olbarbarash timelineforthedoubleantiplatelettherapyfactsandsuggestions
AT vvkashtalap timelineforthedoubleantiplatelettherapyfactsandsuggestions